Results 181 to 190 of about 10,024,591 (280)

Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. [PDF]

J Am Heart Assoc
Hiruma Y, Watanabe A, Aikawa T, Iwagami M, Slipczuk L, Wiley J, Briasoulis A, Secemsky E, Laham R, Kuno T.   +9 more
europepmc   +1 more source

A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xingxing Fan   +4 more
wiley   +1 more source

Smoking Behavior and Major Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.

JAMA Netw Open
Kim HK, Kim MS, Ahn S, Min S, Min SK, Ha J, Han A.   +6 more
europepmc   +1 more source

Psoas Major muscle area as a prognostic marker in peripheral arterial disease: a systematic review and meta-analysis. [PDF]

Front Surg
Fernandes-Carvalho J, Braga-Simões J, Santos-Silva D, Sá-Martins V, Andrade JP, Ribeiro H, Rocha-Neves J.   +6 more
europepmc   +1 more source

Sex‐Stratified Associations of DXA‐Derived Adiposity, Regional Fat Distribution and Muscle Power With Incident Hospitalised Cardiovascular Disease in Older Adults: A Prospective Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the sex‐stratified associations of DXA‐derived adiposity, regional fat distribution and muscle power with incident hospitalised cardiovascular disease (CVD) in older Chinese adults. Materials and Methods This prospective cohort included 3168 community‐dwelling older adults (1548 men and 1620 women; median age 72.0 years ...
Ting Zhang, Yuan Gao, Yafei Wu, Jason Leung, Timothy Kwok   +4 more
wiley   +1 more source

Changes in Muscle Strength Following Semaglutide Treatment in Adults: A Systematic Review With Meta‐Analysis of Handgrip Strength

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To systematically review and quantitatively synthesize within‐group changes in skeletal muscle strength following semaglutide treatment in adults. Materials and Methods This PRISMA 2020 systematic review was registered in PROSPERO (CRD420251185935).
Luís Guilherme Machado, Pedro Henrique Siedschlag Schmidt, Guido Tasca Petroski, Geraldo Lucas Lopes Costa, Letícia Vieira dos Santos Ribeiro, João Victor Ramos Da Cruz, Graziela De Luca Canto, Alexandre Hohl, Marcelo Fernando Ronsoni, Simone van de Sande‐Lee   +9 more
wiley   +1 more source

The Toolkit for Socially Transformative Interventions

The Howard Journal of Crime and Justice, EarlyView.
ABSTRACT Social influences and group‐based dynamics are well‐established factors in the reoffending puzzle, calling for programmes that empower people in prison to re‐develop and strengthen a pro‐social sense of self and belonging as part of a law‐abiding society.
Martha Newson, Linus Peitz
wiley   +1 more source

Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies. [PDF]

Cardiovasc Diabetol
Caruso P, Di Martino N, Longo M, Scappaticcio L, Bellastella G, Maiorino MI, Esposito K, Giugliano D.   +7 more
europepmc   +1 more source

Projected health‐service cost impact of dalbavancin consolidation therapy for Staphylococcus aureus bacteraemia in an Australian public health system

Internal Medicine Journal, EarlyView.
Abstract Background Management of Staphylococcus aureus bacteraemia (SAB) requires prolonged intravenous (IV) antibiotic therapy delivered in hospital or through Hospital in the Home (HITH), often requiring peripherally inserted central catheters (PICCs) and substantial healthcare resources.
Eli Dunn, Yolande Lindsay, Ian Marr, Fabian Chiong   +3 more
wiley   +1 more source

Pharmacokinetics, Safety, and Exploratory 12-Month Clinical Follow-Up of a Novel BIOtorcin™-Coated Balloon for Femoropopliteal Artery Disease: The BRight PK Study. [PDF]

Biomedicines
Lee BJ, Daudu D, Dwyer I, Mwipatayi DL, Wong J, Mwipatayi BP.   +5 more
europepmc   +1 more source